Angiogenesis induced by tumor necrosis factor-α is mediated by α4 integrins

被引:36
作者
Vanderslice P. [1 ,6 ]
Munsch C.L. [2 ]
Rachal E. [1 ]
Erichsen D. [3 ]
Sughrue K.M. [3 ]
Truong A.N. [1 ]
Wygant J.N. [4 ]
McIntyre B.W. [4 ]
Eskin S.G. [2 ]
Tilton R.G. [2 ]
Polverini P.J. [5 ]
机构
[1] Department of Immunology, Texas Biotechnology Corporation, Houston, TX
[2] Department of Cell Biology, Texas Biotechnology Corporation, Houston, TX
[3] Department of Pharmacology, Texas Biotechnology Corporation, Houston, TX
[4] Department of Immunology, Univ. Texas M.D. Anderson Cancer C., Houston, TX
[5] Dept. Oral Med., Pathol. and Surg., University of Michigan, Ann Arbor, MI
[6] Texas Biotechnology Corporation, Houston, TX 77030
关键词
Integrin; Human Umbilical Vein Endothelial Cell; Endothelial Cell Migration; Urokinase Receptor; Peptide Antagonist;
D O I
10.1023/A:1009296700991
中图分类号
学科分类号
摘要
Tumor necrosis factor-α (TNF-α) and fibroblast growth factor-2 (FGF-2 or bFGF) are potent stimulators of angiogenesis. TNF-α, but not FGF-2, can induce the expression of vascular cell adhesion molecule-1 (VCAM-1) on the surface of endothelial cells. The soluble form of VCAM-1 has recently been demonstrated to function as an angiogenic mediator. Here we demonstrate that monoclonal antibodies directed against VCAM-1 or its α4 integrin counter-receptor inhibited TNF-α-induced endothelial cell migration in vitro. Angiogenesis induced in vivo in rat corneas by TNF-α was inhibited by a neutralizing antibody directed against the rat α4 integrin subunit. A peptide antagonist of the α4 integrins blocked TNF-α-induced endothelial cell migration in vitro and angiogenesis in rat corneas in vivo. No inhibition by the antibodies or peptide antagonist was observed either in vitro or in vivo when FGF-2 was used as the stimulus. The peptide antagonist did not inhibit TNF-α binding to its receptor nor did it block the function of αvβ3, an integrin previously implicated in TNF-α and FGF-2 mediated angiogenesis. These results demonstrate that angiogenic processes induced by TNF-α are mediated in part by α4 integrins possibly by a mechanism involving the induction of soluble VCAM-1.
引用
收藏
页码:265 / 275
页数:10
相关论文
共 45 条
[1]  
Folkman J., Angiogenesis in cancer, vascular, rheumatoid and other disease, Nat Med, 1, pp. 27-31, (1995)
[2]  
Koch A.E., Polverini P.J., Kunkel S.L., Et al., Interleukin-8 as a macrophage-derived mediator of angiogenesis, Science, 258, pp. 1798-1801, (1992)
[3]  
Carswell E.A., Old L.J., Kassel R.L., Et al., An endotoxin-induced serum factor that causes necrosis of tumors, Proc Natl Acad Sci USA, 72, pp. 3666-3670, (1975)
[4]  
Schweigerer L., Malerstein B., Gospodarowicz D., Tumor necrosis factor inhibits the proliferation of cultured capillary endothelial cells, Biochem Biophys Res Comm, 143, pp. 997-1004, (1987)
[5]  
Frater-Schroder M., Risau W., Hallman R., Et al., Tumor necrosis factor type α, a potent inhibitor of endothelial cell growth in vitro, is angiogenic in vivo, Proc Natl Acad Sci USA, 84, pp. 5277-5281, (1987)
[6]  
Leibovich S.J., Polverini P.J., Shepard H.M., Et al., Macrophage-induced angiogenesis is mediated by tumor necrosis factor-α, Nature, 329, pp. 630-632, (1987)
[7]  
Fajardo L.F., Kwan H.H., Kowalski J., Et al., Dual role of tumor necrosis factor-α in angiogenesis, Am J Pathol, 140, pp. 539-544, (1992)
[8]  
Montrucchio G., Lupia E., Battaglia E., Et al., Tumor necrosis factor α-induced angiogenesis depends on in situ platelet-activating factor biosynthesis, J Exp Med, 180, pp. 377-382, (1994)
[9]  
Pandey A., Shao H., Marks R.M., Et al., Role of B61, the ligand for the Eck receptor tyrosine kinase, in TNF-α-induced angiogenesis, Science, 268, pp. 567-569, (1995)
[10]  
Yoshida S., Ono M., Shono T., Et al., Involvement of interleukin-8, vascular endothelial growth factor, and basic fibroblast growth factor in tumor necrosis factor alpha-dependent angiogenesis, Mol Cell Biol, 17, pp. 4015-4023, (1997)